Viktor Gruenwald News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viktor Gruenwald, MD, PhD, discusses key results from a post hoc analysis of the phase 3 CLEAR trial in advanced renal cell carcinoma, highlighting the clinical implications of these results.

West germanViktor gruenwaldGerman cancer centerEssen university hospitalWest german cancer centerMedical oncologyRenal cell carcinomaPhase 3 clear trial nct02811861